Context Therapeutics
is an emerging oncology target is a tumor specific protein that is present at high surface density across adult and pediatric cancers selectivity is required to avoid off target liabilities identified in murine knockout studies with pancreas kidney pancreas and ear gut establishes proof of concept for of patients who received car vaccine showed a partial response in an ongoing study in solid tumors elevated and lipase were noted side effects | Context Therapeutics
Company
Deck Type
Sector
Industry
Deck date
September 2022
Slide
16 of 25
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io